Risk factors of avascular necrosis in Takayasu arteritis: a cross sectional study

Rheumatol Int. 2022 Mar;42(3):529-534. doi: 10.1007/s00296-021-04909-0. Epub 2021 Jun 6.

Abstract

Takayasu arteritis (TA) is a large-cell vasculitis, and is not usually associated with avascular necrosis (AVN). The objective of the study was to investigate any association between TA and AVN, including the possible pathogenic effect of glucocorticoid (GCs) use. The study design was retrospective and cross sectional. TA patients were enrolled in the study. Demographic variables, disease activity, treatments, physician global assessment, Indian Takayasu Clinical activity score 2010, and Kerr criteria were recorded. Logistic regression analysis was performed to identify predictors of AVN. A total of 29 patients were assessed. AVN was observed in four (13.8%) patients with TA. Male gender and elevated C-reactive protein (CRP) were found to be significantly associated with AVN (p = 0.001 and p = 0.006, respectively). While type IIb TA was more common in patients with AVN (n = 2, 50%), type V was more likely in the absence of AVN (n = 13, 52%). Descending aorta and thoracic aorta were usually involved in patients with AVN (both, n = 3, 75%). In multivariate logistic regression, increased CRP levels were the only predictor for AVN (OR = 1.183, 95% Cl = 1.025-1.364, p = 0.021). No association was identified between AVN in TA patients and either duration or cumulative dose of GCs. The present study found that higher CRP levels and male gender were associated with AVN in patients with TA.

Keywords: Avascular necrosis; Glucocorticoid; Osteonecrosis; Takayasu arteritis.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • C-Reactive Protein / analysis
  • Causality
  • Cross-Sectional Studies
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Osteonecrosis / complications*
  • Retrospective Studies
  • Risk Factors
  • Takayasu Arteritis / complications*
  • Takayasu Arteritis / drug therapy

Substances

  • Glucocorticoids
  • C-Reactive Protein